4//SEC Filing
Nolan Mangini Siobhan 4
Accession 0001209191-21-007292
CIK 0001426332other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:47 PM ET
Size
5.5 KB
Accession
0001209191-21-007292
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-03+300,000→ 300,000 totalExercise: $18.88Exp: 2030-08-02→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period, with 1/4th vesting on July 13, 2021 and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001679464
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:47 PM ET
- Size
- 5.5 KB